Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-019102
Filing Date
2019-04-10
Accepted
2019-04-10 17:22:05
Documents
5
Period of Report
2019-05-29
Effectiveness Date
2019-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv517873-def14a.htm DEF 14A 517574
2 GRAPHIC tv517873_pc-01.jpg GRAPHIC 570319
3 GRAPHIC tv517873_pc-02.jpg GRAPHIC 255359
4 GRAPHIC tv517873_pc-03.jpg GRAPHIC 233132
5 GRAPHIC tv517873_pc-04.jpg GRAPHIC 200268
  Complete submission text file 0001144204-19-019102.txt   2236619
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 19742314
SIC: 2834 Pharmaceutical Preparations